Home Oncology Immunotherapies

Immunotherapies

Latest
Lymphoma cancer cell, SEM
Immunotherapies

Protein Allows Lymphomas to Develop Immunotherapy Resistance

Immunotherapies

Researchers Link Epigenetics, T Cell Exhaustion, and Methionine to Tumor Growth

PD-1 is a checkpoint to slow down T-cells. PD-1 (red) extends from the surface of a T-cell interacting with the ligand protein PD-L1 (yellow) from an antigen presenting cell.
Immunotherapies

Immuno-Oncology Drug Response Predicted via New Imaging Method

Services that include continuous remote access to tumor specialists and treatment navigators will be made available to community hospitals
Immunotherapies

STING Activation Touted as Potential Immunotherapy for Cancer

Immunotherapies

Potential New Target for Cancer Immunotherapy Identified by German Researchers

Human Kidney Cancer Anatomy
Immunotherapies

Greater Diversity in Gut Microbiome Associated with Better Cancer Immunotherapy Outcomes

Three beautiful young women looking various directions
Immunotherapies

Lower Cancer Immunotherapy Response in Younger Women Due to Their Robust...

Skin cancer, light micrograph
Immunotherapies

Low Amounts of ctDNA Can Predict Good Immunotherapy Outcome

Immunotherapies

Navigating Complexity in Oncology Cell and Gene Therapy Clinical Trials

Immunotherapies

RNA, Data Science, and the Future of Precision Medicine

Load more

New Products

View More
Load more
Copyright © 2020 Genetic Engineering & Biotechnology News. All Rights Reserved.
Scroll Up